Identification of a myotropic AAV by massively parallel in vivo evaluation of barcoded capsid variants
Adeno-associated virus is the basis of many gene therapies and gene transfer vectors. Here the authors report a pipeline to enable side-by-side comparison of pre-selected capsids in a high throughput manner.
Guardado en:
Autores principales: | Jonas Weinmann, Sabrina Weis, Josefine Sippel, Warut Tulalamba, Anca Remes, Jihad El Andari, Anne-Kathrin Herrmann, Quang H. Pham, Christopher Borowski, Susanne Hille, Tanja Schönberger, Norbert Frey, Martin Lenter, Thierry VandenDriessche, Oliver J. Müller, Marinee K. Chuah, Thorsten Lamla, Dirk Grimm |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fcda7a44d2044540880d0f383706efd9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Sub-2 Å Ewald curvature corrected structure of an AAV2 capsid variant
por: Yong Zi Tan, et al.
Publicado: (2018) -
Positron emission tomography imaging of novel AAV capsids maps rapid brain accumulation
por: Jai Woong Seo, et al.
Publicado: (2020) -
Modulating immune responses to AAV by expanded polyclonal T-regs and capsid specific chimeric antigen receptor T-regulatory cells
por: Motahareh Arjomandnejad, et al.
Publicado: (2021) -
Atonal homolog 1 is a tumor suppressor gene.
por: Wouter Bossuyt, et al.
Publicado: (2009) -
Next-generation muscle-directed gene therapy by in silico vector design
por: S. Sarcar, et al.
Publicado: (2019)